IL173206A0 - Heparin-derived oligosaccharide mixtures, preparation thereof and pharmaceutical compositions containing said mixtures - Google Patents

Heparin-derived oligosaccharide mixtures, preparation thereof and pharmaceutical compositions containing said mixtures

Info

Publication number: IL173206A0
Authority: IL; Israel
Prior art keywords: mixtures; heparin; preparation; pharmaceutical compositions; compositions containing
Prior art date: 2003-07-24

Application number

IL173206A

Other versions

IL173206A (en

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-07-24

Filing date

2006-01-17

Publication date

2006-06-11

2006-01-17 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2006-06-11 Publication of IL173206A0 publication Critical patent/IL173206A0/en

2010-11-30 Publication of IL173206A publication Critical patent/IL173206A/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
- C08B37/0078—Degradation products
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Diabetes (AREA)
Cardiology (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Polymers & Plastics (AREA)
Materials Engineering (AREA)
Biochemistry (AREA)
Hospice & Palliative Care (AREA)
Ophthalmology & Optometry (AREA)
Dermatology (AREA)
Obesity (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IL173206A 2003-07-24 2006-01-17 Heparin-derived oligosaccharide mixtures, preparation thereof and pharmaceutical compositions containing said mixtures IL173206A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0309041A FR2857971B1 (en)	2003-07-24	2003-07-24	MIXTURES OF HEPARIN DERIVED OLIGOSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PCT/FR2004/001943 WO2005010051A2 (en)	2003-07-24	2004-07-22	Heparin-derived oligosaccharide mixtures, preparation thereof and pharmaceutical compositions containing said mixtures

Publications (2)

Publication Number	Publication Date
IL173206A0 true IL173206A0 (en)	2006-06-11
IL173206A IL173206A (en)	2010-11-30

Family

ID=33561051

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL173206A IL173206A (en)	2003-07-24	2006-01-17	Heparin-derived oligosaccharide mixtures, preparation thereof and pharmaceutical compositions containing said mixtures

Country Status (40)

Country	Link
EP (1)	EP1651677B1 (en)
JP (1)	JP4865552B2 (en)
KR (1)	KR101125517B1 (en)
CN (1)	CN1852926B (en)
AR (1)	AR045917A1 (en)
AT (1)	ATE487741T1 (en)
AU (1)	AU2004259111B2 (en)
BR (1)	BRPI0412850A (en)
CA (1)	CA2533555A1 (en)
CR (1)	CR8201A (en)
CY (1)	CY1111165T1 (en)
DE (1)	DE602004030015D1 (en)
DK (1)	DK1651677T3 (en)
EC (1)	ECSP066305A (en)
ES (1)	ES2355827T3 (en)
FR (1)	FR2857971B1 (en)
GT (1)	GT200400145A (en)
HK (1)	HK1094806A1 (en)
HN (1)	HN2004000250A (en)
IL (1)	IL173206A (en)
MA (1)	MA27928A1 (en)
ME (1)	MEP11608A (en)
MX (1)	MXPA06000336A (en)
MY (1)	MY136769A (en)
NO (1)	NO20060821L (en)
NZ (1)	NZ544717A (en)
OA (1)	OA13197A (en)
PA (1)	PA8606801A1 (en)
PE (1)	PE20050246A1 (en)
PL (1)	PL1651677T3 (en)
PT (1)	PT1651677E (en)
RS (1)	RS20060044A (en)
RU (1)	RU2346005C2 (en)
SI (1)	SI1651677T1 (en)
TN (1)	TNSN06025A1 (en)
TW (1)	TWI369208B (en)
UA (1)	UA89356C2 (en)
UY (1)	UY28435A1 (en)
WO (1)	WO2005010051A2 (en)
ZA (1)	ZA200600657B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7589145B2 (en)	2004-04-15	2009-09-15	Exxonmobil Chemical Patents Inc.	Syndiotactic rich polyolefins
WO2007140231A2 (en) *	2006-05-25	2007-12-06	Momenta Pharmaceutical, Inc.	Low molecular weight heparin composition and uses thereof
CN101711771B (en) *	2008-10-07	2015-12-09	上海喜恩医药科技发展有限公司	A kind of polysaccharide mixture of heparin derivative and method for making thereof and pharmaceutical composition
WO2012036152A1 (en) *	2010-09-14	2012-03-22	国立大学法人宮崎大学	High purity heparin and production method therefor
WO2012072799A1 (en)	2010-12-02	2012-06-07	Aventis Pharma S.A.	New methods for the in vitro measurement of the biological activity of an ultra low molecular weight heparin sample
CN102558392A (en) *	2010-12-14	2012-07-11	王芃	Preparation method of high-FXa-resistant low-FIIa-resistant low-molecular heparin sodium
CN102816255B (en) *	2011-06-10	2015-11-25	王芃	A kind of preparation method of ultra-low molecular heparin sodium
US9896517B2 (en)	2013-03-26	2018-02-20	Jiuzhitang Co., Ltd.	Low molecular weight glycosaminoglycan derivative, pharmaceutical composition thereof, preparation method therefor and use thereof
CN103864959A (en) *	2014-04-03	2014-06-18	中国药科大学	Application of heparin oligosaccharide dp12 in atherosclerosis resistance
RU2639574C2 (en) *	2016-05-23	2017-12-21	Алексей Георгиевич Александров	Process for low molecular weight heparin preparation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL61201A (en) *	1979-10-05	1984-09-30	Choay Sa	Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
FR2504928A1 (en) *	1981-04-29	1982-11-05	Choay Sa	SHORT CHAIN OLIGOSACCHARIDES HAVING BIOLOGICAL PROPERTIES, PREPARATION THEREOF AND APPLICATIONS THEREOF AS MEDICAMENTS
EP0986581A1 (en) *	1997-06-06	2000-03-22	Hamilton Civic Hospitals Research Development, Inc.	Modified low molecular weight heparin that inhibits clot associated coagulation factors
JP4897991B2 (en) *	1999-07-23	2012-03-14	ラボラトリオスファルマセウティコスロビソシエダッドアノニマ	Ultra low molecular weight heparin composition
ES2161615B1 (en) *	1999-07-23	2003-03-16	Rovi Lab Farmaceut Sa	COMPOSITIONS OF HEPARINS OF VERY LOW MOLECULAR WEIGHT.
FR2800074B1 (en) *	1999-10-22	2001-12-21	Aventis Pharma Sa	NOVEL OLIGOSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
JP4585072B2 (en) *	2000-02-29	2010-11-24	扶桑薬品工業株式会社	Heparin depolymerization method, depolymerized heparin, derivatives thereof and pharmaceutical composition
FR2807043B1 (en) *	2000-03-28	2002-11-22	Aventis Pharma Sa	PHARMACEUTICAL COMPOSITION CONTAINING OLIGOSACCHARIDES, NEW OLIGOSACCHARIDES AND THEIR PREPARATION
FR2811992B1 (en) *	2000-07-21	2003-07-04	Aventis Pharma Sa	MIXTURES OF HEPARIN-DERIVED POLYSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US6969705B2 (en) *	2000-07-21	2005-11-29	Aventis Pharma S.A.	Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
JP2005505537A (en) *	2001-08-28	2005-02-24	レオ・ファーマ・アクティーゼルスカブ	Antithrombotic composition comprising low molecular weight heparin and low molecular weight dermatan sulfate
FR2845686B1 (en) *	2002-10-10	2013-08-30	Aventis Pharma Sa	MIXTURES OF HEPARIN-DERIVED POLYSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

2003
- 2003-07-24 FR FR0309041A patent/FR2857971B1/en not_active Expired - Fee Related
2004
- 2004-07-01 PE PE2004000632A patent/PE20050246A1/en not_active Application Discontinuation
- 2004-07-14 PA PA20048606801A patent/PA8606801A1/en unknown
- 2004-07-19 AR ARP040102549A patent/AR045917A1/en not_active Application Discontinuation
- 2004-07-21 HN HN2004000250A patent/HN2004000250A/en unknown
- 2004-07-22 CA CA002533555A patent/CA2533555A1/en not_active Abandoned
- 2004-07-22 WO PCT/FR2004/001943 patent/WO2005010051A2/en active Application Filing
- 2004-07-22 AU AU2004259111A patent/AU2004259111B2/en not_active Ceased
- 2004-07-22 DE DE602004030015T patent/DE602004030015D1/en not_active Expired - Lifetime
- 2004-07-22 JP JP2006520862A patent/JP4865552B2/en not_active Expired - Fee Related
- 2004-07-22 DK DK04785991.3T patent/DK1651677T3/en active
- 2004-07-22 ES ES04785991T patent/ES2355827T3/en not_active Expired - Lifetime
- 2004-07-22 EP EP04785991A patent/EP1651677B1/en not_active Expired - Lifetime
- 2004-07-22 PT PT04785991T patent/PT1651677E/en unknown
- 2004-07-22 UA UAA200601969A patent/UA89356C2/en unknown
- 2004-07-22 NZ NZ544717A patent/NZ544717A/en unknown
- 2004-07-22 AT AT04785991T patent/ATE487741T1/en active
- 2004-07-22 RS YUP-2006/0044A patent/RS20060044A/en unknown
- 2004-07-22 OA OA1200600025A patent/OA13197A/en unknown
- 2004-07-22 BR BRPI0412850-8A patent/BRPI0412850A/en active Search and Examination
- 2004-07-22 ME MEP-116/08A patent/MEP11608A/en unknown
- 2004-07-22 MX MXPA06000336A patent/MXPA06000336A/en active IP Right Grant
- 2004-07-22 CN CN2004800265420A patent/CN1852926B/en not_active Expired - Fee Related
- 2004-07-22 PL PL04785991T patent/PL1651677T3/en unknown
- 2004-07-22 SI SI200431594T patent/SI1651677T1/en unknown
- 2004-07-22 MY MYPI20042944A patent/MY136769A/en unknown
- 2004-07-22 RU RU2006105384/04A patent/RU2346005C2/en not_active IP Right Cessation
- 2004-07-22 KR KR1020067001609A patent/KR101125517B1/en not_active IP Right Cessation
- 2004-07-23 GT GT200400145A patent/GT200400145A/en unknown
- 2004-07-23 UY UY28435A patent/UY28435A1/en unknown
- 2004-07-23 TW TW093121979A patent/TWI369208B/en not_active IP Right Cessation
2006
- 2006-01-17 IL IL173206A patent/IL173206A/en not_active IP Right Cessation
- 2006-01-18 CR CR8201A patent/CR8201A/en unknown
- 2006-01-20 MA MA28745A patent/MA27928A1/en unknown
- 2006-01-23 ZA ZA200600657A patent/ZA200600657B/en unknown
- 2006-01-23 EC EC2006006305A patent/ECSP066305A/en unknown
- 2006-01-23 TN TNP2006000025A patent/TNSN06025A1/en unknown
- 2006-02-20 NO NO20060821A patent/NO20060821L/en not_active Application Discontinuation
2007
- 2007-01-10 HK HK07100324.0A patent/HK1094806A1/en not_active IP Right Cessation
2011
- 2011-02-04 CY CY20111100132T patent/CY1111165T1/en unknown

Also Published As

Publication number	Publication date
SI1651677T1 (en)	2011-03-31
HN2004000250A (en)	2006-06-29
TNSN06025A1 (en)	2007-10-03
MY136769A (en)	2008-11-28
CR8201A (en)	2006-09-22
OA13197A (en)	2006-12-13
WO2005010051A3 (en)	2005-06-16
MEP11608A (en)	2010-06-10
PE20050246A1 (en)	2005-06-02
FR2857971B1 (en)	2005-08-26
ECSP066305A (en)	2006-07-28
PA8606801A1 (en)	2005-02-04
BRPI0412850A (en)	2006-10-03
TWI369208B (en)	2012-08-01
AU2004259111A1 (en)	2005-02-03
GT200400145A (en)	2005-03-16
KR20060059974A (en)	2006-06-02
HK1094806A1 (en)	2007-04-13
PT1651677E (en)	2011-02-08
WO2005010051A2 (en)	2005-02-03
IL173206A (en)	2010-11-30
RS20060044A (en)	2008-06-05
NO20060821L (en)	2006-04-20
PL1651677T3 (en)	2011-04-29
ZA200600657B (en)	2007-05-30
CA2533555A1 (en)	2005-02-03
JP4865552B2 (en)	2012-02-01
TW200522970A (en)	2005-07-16
JP2006528614A (en)	2006-12-21
NZ544717A (en)	2009-09-25
EP1651677A2 (en)	2006-05-03
CY1111165T1 (en)	2015-06-11
MA27928A1 (en)	2006-06-01
RU2346005C2 (en)	2009-02-10
DE602004030015D1 (en)	2010-12-23
CN1852926A (en)	2006-10-25
MXPA06000336A (en)	2006-03-30
EP1651677B1 (en)	2010-11-10
AR045917A1 (en)	2005-11-16
ES2355827T3 (en)	2011-03-31
KR101125517B1 (en)	2012-03-23
RU2006105384A (en)	2007-09-10
DK1651677T3 (en)	2011-02-28
ATE487741T1 (en)	2010-11-15
AU2004259111B2 (en)	2009-06-11
FR2857971A1 (en)	2005-01-28
CN1852926B (en)	2010-05-12
UA89356C2 (en)	2010-01-25
UY28435A1 (en)	2005-02-28

Legal Events

Date	Code	Title	Description
2011-03-31	FF	Patent granted
2015-02-26	MM9K	Patent not in force due to non-payment of renewal fees

Publication	Publication Date	Title
IL173195A0 (en)	2006-06-11	Cyclovinylazoline derivatives, their preparation and pharmaceutical compositions containing them
HK1094806A1 (en)	2007-04-13	Heparin-derived oligosaccharide mixtures, preparation thereof and pharmaceutical compositions containing said mixtures
IL206831A0 (en)	2011-08-01	Glucopyranosyl derivatives and pharmaceutical compositions containing the same
IL165977A (en)	2010-12-30	Substituted pyrimidinylaminobenzamides , process for the preparation thereof and pharmaceutical compositions comprising the same
IL176005A0 (en)	2006-10-05	2,6-bisheteroaryl-4-aminopyrimidine derivatives and pharmaceutical compositions containing the same
IL164376A0 (en)	2005-12-18	Ox4or binding agents, their preparation and pharmaceutical compositions containing them
IL169500A0 (en)	2007-07-04	Pyrrolopyridazine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL173602A0 (en)	2006-07-05	Heteroarylaminosulfonylphenyl derivatives and pharmaceutical compositions containing the same
IL173627A0 (en)	2006-07-05	2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives and pharmaceutical compositions containing the same
IL173051A0 (en)	2006-06-11	N-glucoside derivatives and pharmaceutical compositions containing the same
IL171997A0 (en)	2011-08-01	Pyrrolodihydroisoquinoline derivatives and pharmaceutical compositions containing the same
IL175214A0 (en)	2006-09-05	2-cyanopyrrolidinecarboxamide derivatives and pharmaceutical compositions containing the same
IL172159A0 (en)	2006-04-10	2-oxo-pyridine derivatives and pharmaceutical compositions containing the same
HUP0700086A2 (en)	2007-05-29	2-aminopyridine compounds, use thereof as drugs and pharmaceutical compositions containing them
IL169818A0 (en)	2007-07-04	Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them
IL165388A0 (en)	2006-01-15	Macrolide compounds and pharmaceutical compositions containing the same
ZA200702226B (en)	2009-01-28	Compounds, compositions containing them, preparations thereof and uses thereof II
IL154370A0 (en)	2003-09-17	Solid amorphous mixtures, processes for the preparation thereof and pharmaceutical compositions containing the same
HK1059273A1 (en)	2004-06-25	Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same
IL174317A0 (en)	2006-08-01	Triterpene derivatives and pharmaceutical compositions containing the same
PL394600A1 (en)	2011-07-18	Vinylazocycloalkanyl compound, process for the preparation thereof, its use and pharmaceutical composition
HUP0401522A2 (en)	2006-04-28	New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation
IL176077A0 (en)	2006-10-05	1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them
IL174252A0 (en)	2006-08-01	Benzoxazole acetonitrile derivatives, their preparation and pharmaceutical compositions containing them
IL181216A0 (en)	2007-07-04	3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same